Catalyst Wire Dossier Catalyst Wire Dossier

Salmeterol inhalation powder (HandiHaler 2)

salmeterol · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Salmeterol inhalation powder (HandiHaler 2), covering 2014-09-17 to 2014-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

See pricing